Provider
Antidepressant - Medicaid
Quantity Limit
Program effective Date: Jun 01, 2025
Search Results
Displaying 1461 - 1470 of 3697 results
Provider
QP60-23 Commercial Pharmacy Benefit Exclusion for Elfabrio®, Vyjuvek™
Program effective Date: Jul 12, 2023
Provider
QP61-23 MHCP Pharmacy Benefit Exclusion for Elfabrio®, Epkinly™, and Vyjuvek™
Program effective Date: Jul 12, 2023
Provider
QP62-23 Commercial Pharmacy Benefit Update: Revised Drug-Related Prior Authorization (PA) Requirement Notification, Effective September 1, 2023
Program effective Date: Jul 12, 2023
Provider
2023 July Bulletins
Program effective Date: Jul 03, 2023
Provider
Lyrica (pregabalin) Savella (milnacipran) - Commercial
Step Therapy, Quantity Limit
Program effective Date: Jun 01, 2025
Provider
Furoscix (furosemide) - Commercial
Prior Authorization, Quantity Limit
Program effective Date: Aug 01, 2025
Provider
QP63-23 MHCP Pharmacy Benefit Update: Revised Drug-Related Prior Authorization (PA) Requirement Notification, Effective August 1, 2023
Program effective Date: Jul 12, 2023
Provider
QP64-23 Medical Drug Update for New to Market Valoctocogene Roxaparvovec (Roctavian, f.k.a. Valrox)
Program effective Date: Jul 12, 2023
Financial Information
Provider
commercial-em-007-critical-care-services.pdf